Objective 200,000,000. This is the sad number of people in the EU that currently suffer pain due to improperly formed feet and adequate orthotic support. This number is expected to rise sharply in the next years due to increasingly aging demographics and decreased physical activity. An improperly formed foot that is unaddressed by adequate orthotic support inevitably results in disabling musculoskeletal problems later in life. In this light it is unacceptable that currently 2 out of 5 orthotic insoles are improperly designed due to poor diagnosis, design or production. Current systems for designing orthotic soles are static and do not take into account pressure points or dynamic movement of the patient. Furthermore, these systems are highly dependent of the individual technical expertise of the insole designer and manufacturer. This along with the decreasing number of orthotics professionals in Europe leads to a decline in the overall quality and availability of adequate orthotic insoles.Based on the knowledge acquired from extensive diagnosing and treating, LKZ has developed OrmoSys, a complete system for the diagnosis and treatment of foot and postural ailments. Building on standardised tests and powerful algorithms, an ICT-system recommends fully customised orthotic insoles. By combining a limited number of shapes and materials, OrmoSys allows for 39,744 different insole types which precisely address the patients’ problems. Built on proven technical knowledge, this orthotic modular system allows unskilled operators with low experience to develop quality and consistent orthotic insoles, with less room for errors.The goal of the project is to produce the current prototype (TRL7) to meet the identified market requirements, i.e. high product quality and customer satisfaction, easy to handle, acceptable price. This will facilitate the successful introduction of OrmoSys in the identified markets for comfort, sport and medical orthotic insoles, thus addressing an 18bn € market. Fields of science medical and health sciencesclinical medicineendocrinologydiabetesengineering and technologymedical engineeringwearable medical technology Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.4. - Active ageing and self-management of health H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument H2020-EU.3.1.6. - Health care provision and integrated care Topic(s) SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well Call for proposal H2020-SMEInst-2016-2017 See other projects for this call Sub call H2020-SMEINST-2-2016-2017 Funding Scheme SME-2 - SME instrument phase 2 Coordinator LANGMEIER FATMIR FETULA Net EU contribution € 1 871 625,00 Address Germany See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 2 673 750,00
